ZENTALIS PHARMACEUTICALS INC (ZNTL) Stock Cash Flow
NASDAQ:ZNTL - Nasdaq - US98943L1070 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -224.19M | -165.87M | -292.31M | -237.11M | -166.09M | |||
| Depreciation Amortization | 1.23M | 1.29M | 1.39M | 1.43M | 540.00K | |||
| Income Taxes - Deferred | N/A | 0.00 | -853.00K | -770.00K | 0.00 | |||
| Change In Working Capital | 1.52M | -16.54M | 5.86M | 13.25M | 16.56M | |||
| Taxes Paid | N/A | 359.00K | 140.00K | 10.00K | 20.00K | |||
| Other non cash items | 69.92M | 10.26M | 78.08M | 59.45M | -5.10M | |||
| OPERATING CASH FLOW | -151.52M | -170.86M | -207.82M | -163.75M | -154.09M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -181.00K | -221.00K | -583.00K | -2.55M | -6.11M | |||
| Other Investing Activity | 155.67M | 176.78M | -43.88M | -111.63M | -12.01M | |||
| INVESTING CASH FLOW | 155.49M | 176.56M | -44.46M | -114.18M | -18.12M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 290.00K | 349.00K | 237.30M | 261.04M | 179.67M | |||
| Other Financing Activity | 0.00 | -241.00K | 0.00 | 0.00 | -1.15M | |||
| FINANCING CASH FLOW | 290.00K | 108.00K | 237.30M | 261.04M | 178.52M | |||
| CHANGE IN CASH | 4.26M | 5.81M | -14.98M | -16.89M | 6.31M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -151.52M | -170.86M | -207.82M | -163.75M | -154.09M | |||
| Capital Expenditure | -181.00K | -221.00K | -583.00K | -2.55M | -6.11M | |||
| FREE CASH FLOW | -151.70M | -171.08M | -208.41M | -166.30M | -160.20M | |||
All data in USD